Brain Advance Access originally published online on February 25, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 127, No. 4, 900-913, 2004
© 2004 Guarantors of Brain
doi: 10.1093/brain/awh109
5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study
1 EA1880, Federal Institute of Neurosciences (IFR19), Lyon, 2 INSERM, 3 Debrousse Hospital, EEG Department, Lyon, 4 CERMEP, PET Center, Lyon, 5 CNRS and 6 Neurological Hospital, EEG Department, Lyon, France
Correspondence to: Isabelle Merlet, CERMEP, 59 boulevard Pinel, 69003 Lyon, FranceE-mail: merlet{at}cermep.fr
The aim of our study was to assess abnormalities in 5-hydroxytryptamine-1A (5-HT1A) receptor density in patients suffering from refractory temporal lobe epilepsy (TLE). Experimental data in animals show that 5-HT1A receptors are predominantly located in limbic areas, and that serotonin, via these receptors, mediates an antiepileptic and anticonvulsant effect. In TLE patients, we quantified 5-HT1A receptor density in epileptogenic and non-epileptogenic areas, as defined by intracranial recordings with stereo-electroencephalography (SEEG). Nine TLE patients and 53 control subjects were studied by PET using a 5-HT1A receptor antagonist ([18F]MPPF). Anatomical regions of interest (ROIs) were drawn on patient and control MRIs co-registered with PET. PET data were quantified using a simplified model to assess binding potential (BP) values in each ROI, with cerebellum as reference. For each patient, a normalized percentage BP change was calculated as the relative variation of BP in each ROI compared with the corresponding ROI in control subjects. In patients, ROIs explored by SEEG were categorized according to their degree of epileptic activity (ictal onset, ictal spreading, interictal spikes, no epileptic activity) and according to their lesional aspect and volume (lesional with volume loss, lesional without volume loss, non-lesional). Compared with control values, the binding to 5-HT1A receptors in TLE patients was decreased in the epileptogenic temporal lobe. BP decrease was significantly greater in: (i) regions involved in the seizure onset than regions where only interictal paroxysms or no epileptic activity was recorded; and (ii) regions where the discharge propagated than regions where only interictal paroxysms or no epileptic activity was recorded. BP decrease was shown to be significantly influenced by the existence of a lesion on MRI. However, in the group of ROIs with normal quantitative and qualitative MRI aspect, BP decrease remained strongly correlated to the degree of epileptic activity. This study shows that in vivo availability of 5-HT1A receptors is decreased in epileptic patients compared with normal subjects. This decrease is highly correlated to the degree of epileptogenicity of cortical areas explored by intracerebral recordings, and does not reflect only pathological changes or neuronal loss in the epileptic focus.
Key Words: 5-HT1A receptors; intracerebral recordings; PET; serotonin; temporal lobe epilepsy
Abbreviations:
AED = antiepileptic drug; AMT = 
-[11C]methyl-L-tryptophan; BP = binding potential; 5-HT1A = 5-hydroxytryptamine-1A; IS = interictal spiking activity only; NE = no epileptic activity; NI = non-implanted; ROI = region of interest; SEEG = stereo-electroencephalography TLE = temporal lobe epilepsy
Received July 11, 2003. Revised October 23, 2003. Accepted December 14, 2003.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Lothe, A. Didelot, A. Hammers, N. Costes, M. Saoud, F. Gilliam, and P. Ryvlin Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study Brain, September 2, 2008; (2008) awn194v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Truchot, S. N. Costes, L. Zimmer, B. Laurent, D. Le Bars, C. Thomas-Anterion, B. Croisile, B. Mercier, M. Hermier, A. Vighetto, et al. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment Neurology, September 4, 2007; 69(10): 1012 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Costes, L. Zimmer, A. Reilhac, F. Lavenne, P. Ryvlin, and D. Le Bars Test Retest Reproducibility of 18F-MPPF PET in Healthy Humans: A Reliability Study J. Nucl. Med., August 1, 2007; 48(8): 1279 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Hurley, R. Fisher, and K. H. Taber Sudden Onset Panic: Epileptic Aura or Panic Disorder? J Neuropsychiatry Clin Neurosci, November 1, 2006; 18(4): 436 - 443. [Full Text] [PDF]
|
|
|
|
|
|
N. Saigal, R. Pichika, B. Easwaramoorthy, D. Collins, B. T. Christian, B. Shi, T. K. Narayanan, S. G. Potkin, and J. Mukherjee Synthesis and Biologic Evaluation of a Novel Serotonin 5-HT1A Receptor Radioligand, 18F-Labeled Mefway, in Rodents and Imaging by PET in a Nonhuman Primate J. Nucl. Med., October 1, 2006; 47(10): 1697 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jamali, F. Bartolomei, A. Robaglia-Schlupp, A. Massacrier, J.-C. Peragut, J. Regis, H. Dufour, R. Ravid, P. Roll, S. Pereira, et al. Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex Brain, March 1, 2006; 129(3): 625 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Thivard, C. Adam, D. Hasboun, S. Clemenceau, E. Dezamis, S. Lehericy, D. Dormont, J. Chiras, M. Baulac, and S. Dupont Interictal diffusion MRI in partial epilepsies explored with intracerebral electrodes Brain, February 1, 2006; 129(2): 375 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Costes, I. Merlet, K. Ostrowsky, I. Faillenot, F. Lavenne, L. Zimmer, P. Ryvlin, and D. Le Bars A 18F-MPPF PET Normative Database of 5-HT1A Receptor Binding in Men and Women Over Aging J. Nucl. Med., December 1, 2005; 46(12): 1980 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Y. Joo, S. B. Hong, H. J. Han, W. S. Tae, J. H. Kim, S. J. Han, D. W. Seo, K.-H. Lee, S.-C. Hong, M. Lee, et al. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy Brain, August 1, 2005; 128(8): 1802 - 1810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Giovacchini, M. T. Toczek, R. Bonwetsch, A. Bagic, L. Lang, C. Fraser, P. Reeves-Tyer, P. Herscovitch, W. C. Eckelman, R. E. Carson, et al. 5-HT1A Receptors Are Reduced in Temporal Lobe Epilepsy After Partial-Volume Correction J. Nucl. Med., July 1, 2005; 46(7): 1128 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Meschaks, P. Lindstrom, C. Halldin, L. Farde, and I. Savic Regional Reductions in Serotonin 1A Receptor Binding in Juvenile Myoclonic Epilepsy Arch Neurol, June 1, 2005; 62(6): 946 - 950. [Abstract] [Full Text] [PDF]
|
|